Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


08.10.2018

1 Ann Surg Oncol
1 Anticancer Res
1 Cancer
1 J Am Acad Dermatol
2 Melanoma Res
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. AMIT M, Hanna EY
    ASO Author Reflections: Treatment Approaches to Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Sep 28. pii: 10.1245/s10434-018-6815.
    PubMed     Text format    


    Anticancer Res

  2. ORANGES CM, Sisti G, Nasioudis D, Tremp M, et al
    Hard Palate Melanoma: A Population-based Analysis of Epidemiology and Survival Outcomes.
    Anticancer Res. 2018;38:5811-5817.
    PubMed     Text format     Abstract available


    Cancer

  3. JETER JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, et al
    Chemoprevention agents for melanoma: a path forward into phase 3 clinical trials.
    Cancer. 2018 Oct 3. doi: 10.1002/cncr.31719.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  4. DALMASSO B, Pastorino L, Ciccarese G, Andreotti V, et al
    CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
    J Am Acad Dermatol. 2018 Sep 28. pii: S0190-9622(18)32367.
    PubMed     Text format     Abstract available


    Melanoma Res

  5. HALFPENNY NJA, Scott DA, Thompson JC, Gurung B, et al
    A practical approach to predict expansion of evidence networks: a case study in treatment-naive advanced melanoma.
    Melanoma Res. 2018 Sep 29. doi: 10.1097/CMR.0000000000000513.
    PubMed     Text format     Abstract available

  6. HWANG SJE, Park JJW, Wakade D, Chou S, et al
    Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma.
    Melanoma Res. 2018 Sep 29. doi: 10.1097/CMR.0000000000000518.
    PubMed     Text format     Abstract available


    PLoS One

  7. KAZMIERCZAK PM, Burton NC, Keinrath G, Hirner-Eppeneder H, et al
    Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma.
    PLoS One. 2018;13:e0204930.
    PubMed     Text format     Abstract available

  8. RICHTIG G, Hoeller C, Wolf M, Wolf I, et al
    Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study.
    PLoS One. 2018;13:e0204729.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  9. YANG Y, Jang GB, Yang X, Wang Q, et al
    Central role of autophagic UVRAG in melanogenesis and the suntan response.
    Proc Natl Acad Sci U S A. 2018;115:E7728-E7737.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: